This brand name is authorized in Australia, Hong Kong, New Zealand
The drug CLOPINE contains one active pharmaceutical ingredient (API):
|
1
Clozapine
UNII J60AR2IKIC - CLOZAPINE
|
|
Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AH02 | Clozapine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10288L, 10289M, 10302F, 10341G, 10358E, 5626D, 5627E, 5628F, 5629G, 5630H, 6101D, 6102E, 6417R, 6418T, 9632Y |
| Country: HK | Department of Health Drug Office | Identifier(s): 57650, 57651 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11294, 11295, 8528, 8529 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
